Trustmark National Bank Trust Department’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,737
Closed -$549K 295
2024
Q3
$549K Sell
8,737
-5,062
-37% -$295K 0.04% 194
2024
Q2
$815K Sell
13,799
-10,248
-43% -$641K 0.07% 168
2024
Q1
$1.92M Buy
24,047
+20,516
+581% +$1.57M 0.16% 111
2023
Q4
$279K Sell
3,531
-263
-7% -$18.7K 0.03% 220
2023
Q3
$265K Sell
3,794
-2,489
-40% -$176K 0.03% 219
2023
Q2
$434K Sell
6,283
-1,963
-24% -$140K 0.04% 194
2023
Q1
$613K Sell
8,246
-10,492
-56% -$880K 0.06% 182
2022
Q4
$1.75M Buy
18,738
+258
+1% +$24.9K 0.16% 106
2022
Q3
$1.76M Sell
18,480
-1,851
-9% -$183K 0.17% 100
2022
Q2
$1.88M Sell
20,331
-678
-3% -$66.2K 0.17% 100
2022
Q1
$2.13M Buy
21,009
+1,265
+6% +$133K 0.17% 100
2021
Q4
$2.04M Hold
19,744
0.16% 109
2021
Q3
$1.68M Sell
19,744
-721
-4% -$60.4K 0.13% 118
2021
Q2
$1.71M Buy
20,465
+689
+3% +$56.4K 0.14% 115
2021
Q1
$1.49M Buy
19,776
+6,338
+47% +$462K 0.12% 123
2020
Q4
$918K Sell
13,438
-1,762
-12% -$115K 0.08% 133
2020
Q3
$888K Sell
15,200
-855
-5% -$53.2K 0.09% 130
2020
Q2
$1.04M Buy
16,055
+6,185
+63% +$389K 0.11% 120
2020
Q1
$586K Sell
9,870
-365
-4% -$24.4K 0.07% 145
2019
Q4
$760K Buy
10,235
+1,109
+12% +$77.9K 0.07% 136
2019
Q3
$576K Sell
9,126
-4,380
-32% -$260K 0.06% 151
2019
Q2
$736K Buy
13,506
+2,055
+18% +$111K 0.07% 134
2019
Q1
$618K Buy
11,451
+6,655
+139% +$411K 0.06% 145
2018
Q4
$314K Buy
4,796
+4,287
+842% +$320K 0.04% 186
2018
Q3
$41K Buy
+509
New +$36.4K ﹤0.01% 383
2018
Q1
Sell
-4,968
Closed -$360K 268
2017
Q4
$360K Buy
4,968
+2,146
+76% +$156K 0.04% 204
2017
Q3
$230K Sell
2,822
-158
-5% -$12.5K 0.03% 244
2017
Q2
$241K Sell
2,980
-90
-3% -$7.11K 0.03% 237
2017
Q1
$241K Sell
3,070
-2,014
-40% -$161K 0.03% 234
2016
Q4
$401K Sell
5,084
-2,241
-31% -$181K 0.05% 183
2016
Q3
$652K Sell
7,325
-3,550
-33% -$335K 0.08% 157
2016
Q2
$1.04M Buy
10,875
+11
+0.1% +$1.1K 0.13% 131
2016
Q1
$1.13M Buy
10,864
+3,340
+44% +$325K 0.15% 122
2015
Q4
$736K Sell
7,524
-9,551
-56% -$935K 0.1% 158
2015
Q3
$1.65M Sell
17,075
-68
-0.4% -$7.15K 0.23% 94
2015
Q2
$1.8M Buy
17,143
+140
+0.8% +$14.3K 0.24% 91
2015
Q1
$1.75M Sell
17,003
-1,497
-8% -$151K 0.23% 95
2014
Q4
$1.78M Sell
18,500
-1,000
-5% -$88.1K 0.24% 97
2014
Q3
$1.55M Buy
19,500
+30
+0.2% +$2.37K 0.22% 103
2014
Q2
$1.47M Sell
19,470
-160
-0.8% -$12.1K 0.17% 108
2014
Q1
$1.47M Buy
19,630
+2,086
+12% +$147K 0.17% 111
2013
Q4
$1.26M Buy
17,544
+837
+5% +$53.8K 0.15% 122
2013
Q3
$949K Buy
16,707
+2,085
+14% +$124K 0.12% 141
2013
Q2
$836K Buy
+14,622
New +$847K 0.11% 148

Other funds holding CVS

Trustmark National Bank Trust Department's CVS Position: Q4 2024 in Review

Trustmark National Bank Trust Department sold out of CVS Health (CVS) in Q4 2024, closing a stake of 8,737 shares — an estimated $549K sold.

Trustmark National Bank Trust Department first reported a position in CVS in Q2 2013 and held it in 44 quarters. The position peaked at $2.13M in Q1 2022. 1,670 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Trustmark National Bank Trust Department reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 8,737 CVS Health shares in Q4 2024, an estimated $549K.
  • Trustmark National Bank Trust Department first reported a position in CVS Health in Q2 2013 and held it in 44 quarters.
  • Trustmark National Bank Trust Department's CVS Health position peaked at $2.13M in Q1 2022.
  • 1,670 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Trustmark National Bank Trust Department's 13F filing for Q4 2024, filed 13 Feb 2025.